The Stanley
Laboratory of the Johns Hopkins University
The Stanley
Laboratory was founded in 1996 to promote research into the role of infectious
agents in the etiology and pathogenesis of schizophrenia and bipolar disorder.
The Stanley Laboratory is fully supported by the Stanley Medical Research
Institute (www.stanleyresearch.org).
Some of the scientific background of the Laboratory’s research studies can be
found under here. Recent publications
can be found here.
Some of the
activities of the Stanley Laboratory include:
A post doctoral
which provides training in the fields of neuro-virology, neuropathology, and the
epidemiology of serious psychiatric diseases.
An
annual symposium on a topic related to the
biology of brain diseases.
Serologic
Studies. We have a robotic system which can perform large scale analyses
of serum and cerebrospinal fluids for antibodies to a range of infectious agents
including Herpes Simplex Virus Type 1, Herpes Simplex Virus Type 2,
Cytomegalovirus, Epstein-Barr Virus, Human Herpes Virus Type6, Toxoplasma
gondii, Influenza A Virus and Influenza B Virus. These assays are
performed free of charge for collaborators.
Scientific
Collaborations: The Stanley Laboratory is interested in the performance of
collaborative studies with laboratories interested in the study of human
psychiatric diseases. Some of the ongoing collaborating institutions are:
Department of Neurovirology, Karolinska Institute, Stockholm Sweden
Department of Psychiatry, University of Heidelberg
Department of Psychiatry, University of Cologne
Department of Epidemiology, Harvard School of Public Health
Department of Pharmacology, University of Maryland
Department of Psychiatry, University of Cambridge
Department of Medical Microbiology, Washington University of St. Louis
Department of Psychology, Sheppard Pratt Health System, Baltimore, MD
Roveka Laboratories, Gaithersburg, MD
Centre for Register-Based Research, Aarhus, Denmark
Department of Human Genetics, University of Pittsburgh